Abstract
Established methods for definitive ablation of autonomous thyroid nodules are surgery and radioiodine. Since it has been demonstrated that percutaneous ethanol injection can inactivate parathyroid adenomas and small hepatocellular carcinomas, we started a trial of this treatment in patients with autonomous thyroid nodules. Twenty-eight patients, 22 toxic and 6 nontoxic, all with undetectable thyrotropin serum levels and suppressed extranodular tissue on scintigraphy, were treated. Treatment consisted of percutaneous intranodular ethanol injection under ultrasound guidance. The total amount of alcohol injected ranged from 0.4 to 2.2 times the estimated nodule volume, divided into 4 to 9 injections performed at 2 to 7 day intervals. Most patients were treated with a single cycle of injections, but 7 of them required 2 cycles. The signs and symptoms of hyperthyroidism disappeared in all cases. Apparently complete cure (normal serum free thyroid hormones, thyrotropin in basal conditions and after thyrotropin releasing hormone, reactivation of extranodular tissue on scintigraphy with nodule no longer visible) was obtained in 17 patients (13 after 1 cycle and 4 after 2 cycles). Partial cure (normal serum free thyroid hormone levels, detectable thyrotropin levels with normal or blunted response to thyrotropin releasing hormone and partial reactivation of extranodular tissue on scintigraphy with nodule or parts of it still visible) was obtained in 10 patients (8 after 1 cycle and 2 after 2 cycles). In 1 patient with a very large nodule thyrotropin levels remained undetectable, but thyroid hormone levels eventually became normal. No recurrences were observed after a follow-up of 12 to 32 months (mean 20 months). No serious side effects were encountered. A clinically valuable result was obtained in all patients. These data suggest that this form of treatment could constitute an alternative to surgery and radioiodine for the ablation of autonomous thyroid nodules.
Similar content being viewed by others
References
Hamburger J.I. The autonomously functioning thyroid nodule: Goetsch’s disease. Endocr. Rev. 8:439, 1987.
Weiner J.D. Plummer’s disease: localized thyroid autonomy. J. Endocrinol. Invest. 10:207, 1987.
Livraghi T., Paracchi A., Ferrari C., Bergonzi M., Garavaglia G., Raineri P., Vettori C. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: Preliminary results. Radiology 175: 827, 1990.
Monzani F., Goletti O., De Negri F., Del Guerra P., Lippolis P.V., Caraccio N., Chiarugi M., Ferdeghini M., Baschieri L. Autonomous thyroid nodule and percutaneous ethanol injection. Lancet 337: 743, 1991.
Rieger R., Pimpl W., Money S., Rettembacher L, Galvan G. Hyperthyroidism and concurrent thyroid malignancies. Surgery 106:6, 1989.
Romelli P.B., Pennisi F., Vancheri L. Measurement of free thyroid hormones in serum by adsorption chromatography and radioimmunoassay J. Endocrinol. Invest. 2:25, 1979.
Horst W., Rosier H., Schneider C., Labhart A. 306 cases of toxic adenoma: Clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology; results of 131–I and surgical treatment. J. Nucl. Med. 8:515, 1967.
Livraghi T., Festi D., Monti F., Salmi A., Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 161:309, 1986.
Livraghi T., Salmi A., Bolondi L, Marin G., Arienti V., Monti F., Vettori C. Small hepatocellular carcinoma: percutaneous alcohol injection. Results in 23 patients. Radiology 768:313, 1988.
Ebara M., Ohto M., Sugiura N., Kita K., Yoshikawa M., Okuda K., Kondo F., Kondo Y. Percutaneous ethanol injection for the treatment of small hepatocellular carcinomas. Study of 95 pa tients. J. Gastroenterol. Hepatol. 5:616, 1990.
Livraghi T., Vettori C. Percutaneous ethanol injection therapy of hepatoma. Cardiovasc. Intervent. Radiol. 13:146, 1990.
Karstrup S., Holm H.H., Torp-Pedersen S., Hegedus L. Ultrasonically guided percutaneous inactivation of parathyroid tumors. Br. J. Radiol. 60:667, 1987.
Karstrup S., Lohela P., Apaja-Sarkkinen M., Borgmastars H., Holopeinen O. Non-operative inactivation of a parathyroid tumor in a patient with hypercalcaemic crisis. Acta Med. Scand. 224:197, 1988.
Charboneau J.W., Hay I.D., Van-Heerden J.A. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin. Proc. 63: 913, 1988.
Verges B., Cercueil J.P., Pfitzenmeyer P., Pascaud F., Vailant G., Brun J.M., Putelat R. Percutaneous ethanol injection of parathyroid ade nomas in primary hyperparathyroidism. Lancet 337:1421, 1991.
Solbiati L, Giangrande A., De Pra L, Bellotti E., Cantù P., Ravetto C. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 755:607, 1985.
Vagenakis A.G., Braverman L.E., Azizi F., Portnay G.I., Ingbar S.H. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N. Engl. J. Med. 298:681, 1975.
Mariotti S., Martino E., Francesconi M., Ceccarelli C., Grasso L., Lippi F., Baschieri L., Pinchera A. Serum thyroid autoantibodies as a risk factor for de velopment of hypothyroidism after radioactive iodine therapy for single thyroid “hot” nodule. Acta Endocrinol. (Copenh.) 113:500, 1986.
Ng Tang Fui S.C., Maisey M.N. Standard dose 131-1 therapy for hyperthyroidism caused by autonomously functioning thyroid nodules. Clin. Endocrinol. (Oxf.) 70:69, 1979.
Eyre-Brook I.A., Talbot C.H. The treatment of autonomous functioning thyroid nodules. Br. J.Surg. 69:577, 1982.
Goldstein R., Hart I.R. Follow-up of solitary autonomous thyroid nodules treated with 131-1. N. Engl. J. Med. 309:1473, 1983.
Ross D.S., Ridgway E.C., Daniels G.H. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low preva lence of hypothyroidism. Ann. Intern. Med. 707:488, 1984.
Hegedus L., Veiergang D., Karstrup S., Molholm Hansen J. Compensated 131–I therapy of solitary autonomous thyroid nodules; effect on thyroid size and early hypothyroidism. Acta Endocrinol. (Copenh.) 778:226, 1986.
Heinze H.G., Bohn U. 131 Jod-Therapie des autonomen Adenoms der Schilddruse. Dtsch. Med. Wochenschr. 772:1073, 1987.
Kinser J.A., Roesler H., Furrer T., Grutter D., Zimmermann H. Nonimmunogenic hyperthyroidism: Cumulative hypothyroidism incidence after radioiodine and surgical treatment. J. Nucl. Med. 30:1960, 1989.
Huysmans D.A, Corstens F.H., Kloppenborg P.W. Long-term follow-up in toxic solitary autonomous thy roid nodules treated with radioactive iodine. J. Nucl. Med. 32:21, 1991.
Berglund J., Christensen S.B., Dymling J.F., Hallengren B. The incidence of recurrences and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmo during the period 1970–1974. J. Intern. Med. 229:435, 1991.
Molnar G.D., Wilber R.D., Lee R.E., Woolner L.B., Keating F: R. On the hyperfunctioning solitary thyroid nodule. Mayo Clin. Proc. 40:665, 1965.
Blum M., Shenkman L., Hollander C.S. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am. J. Med. Sci. 269: 43, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paracchi, A., Ferrari, C., Livraghi, T. et al. Percutaneous intranodular ethanol injection: A new treatment for autonomous thyroid adenoma. J Endocrinol Invest 15, 353–362 (1992). https://doi.org/10.1007/BF03348753
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348753